HIGHER CYCLOSPORINE LEVELS DECREASE KIDNEY REJECTION EPISODES WITHOUT INCREASING NEPHROTOXICITY

303 PURPOSE: Cyclosporine has become the mainstay of immunosuppression for renal transplant patients. Controversy persists, however, regarding the optimal level of cyclosporine that should be maintained for maximum immunosuppressive benefits and minimal toxicity. Because acute rejection episodes hav... View More